Stockreport

Elicio Therapeutics Reports Inducement Grants

Elicio Therapeutics, Inc.  (ELTX) 
PDF BOSTON, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pip [Read more]